DELSOL Avocats advised Mutuelle Complémentaire des Agents Publics on the sale of its office building
DELSOL Avocats advised Mutuelle Complémentaire des Agents Publics (MCVPAP) on the sale of its office building (2,760 m²) located in the Marais district at 52 rue de Sévigné in Paris to the Pontine group as part of a value-added transaction. In the context of this transaction, DELSOL Avocats advised Mutuelle Complémentaire des Agents Publics with […]
Major contributions by the CJEU on the concepts of pseudonymisation and personal data
In a judgment dated September 4th, 2025 ] , the Court of Justice of the European Union (CJEU) provided major clarifications regarding the concept of personal data. In this case, the Court was asked to rule, in particular, on the qualification, in terms of the definition of personal data, of comments made by individuals to […]
AI Regulation: distribution of responsibilities between French national authorities
On 9 September, in accordance with the Regulation on artificial intelligence (“AI Act”) ], the French Ministry of Economy and Finance unveiled the list of national authorities responsible for artificial intelligence and the division of their respective powers . The diagram presented by Bercy distinguishes between the authorities responsible for: As specified by the Directorate-General […]
DELSOL Avocats advised Caisse d’Epargne Loire Drôme Ardèche on the acquisition of Weba Grupa
DELSOL Avocats advised the mezzanine investor, Caisse d’Epargne Loire Drôme Ardèche (CELDA), on the acquisition of Weba Grupa by the Clesse Group, owned by InnovaFonds. Clesse, a manufacturer of gas equipment (pressure regulators, hoses, valves, fittings, etc.) based near Clermont-Ferrand (France), has acquired the Polish company Weba. This acquisition gives the group control of a […]
Appeal seeking annulment of the Data Privacy Framework dismissed
In a ruling dated September 3, 2025 ] , the General Court of the European Union (“GCEU”) dismissed the appeal brought by the French member of parliament Philippe Latombe, seeking annulment of the “Data Privacy Framework” established by the European Commission’s adequacy decision of July 10, 2023, allowing the transfer of personal data from the […]
DELSOL Avocats advised Entrepreneur IM on the Safeguard Plan of Keller Williams France
On 6 August 2025, the Antibes (France) Commercial Court approved the Safeguard Plan of Keller Williams France, the French franchisee of the eponymous American real estate group. With liabilities totalling €17.8 million, the company was able to benefit from provisions for affected parties. Its plan was validated, and it is now benefiting from a five-year […]
PRESS RELEASE – DELSOL Avocats strengthens its Real estate and Construction practice with the arrival of Hélène Laborde as a partner
DELSOL Avocats, a multi-disciplinary business law firm that assists its clients both in France and abroad, announces the arrival of Hélène Laborde as a partner in the “Real Estate – Construction” department. Hélène joins the firm with a senior associate, Jordan Sochay, and will support Nathalie Peyron’s practice, which focuses on construction law (project management […]
PRESS RELEASE – DELSOL Avocats advises Demeter on its investment in Praysbee
DELSOL Avocats has advised Demeter, a major European player in venture capital, development capital and infrastructure investment in the energy and ecological transition, on the fundraising of Praysbee, a company deploying innovative wine spraying technology. Praysbee has announced the closing of a €3 million financing round led by Demeter, via its VitiRev Innovation fund, and […]
PRESS RELEASE – DELSOL Avocats advises AGORiA Santé on obtaining the CNIL’s 1st authorization to combine biology and SNDS data
DELSOL Avocats has advised the AGORiA Santé consortium, in partnership with BIOGROUP, on obtaining the CNIL’s (French data protection authoritys) first authorization to combine biology and SNDS (French national health data system) data in a health data warehouse. Created in 2021, the AGORIA Santé consortium comprises AstraZeneca France, Takeda France, Impact Healthcare and Docaposte, its […]
Publication of the code of practice for general purpose AI models
On 10 July 2025, the code of practice (“Code”) for general purpose artificial intelligence models (“GPAI models”) was published. Provided for in Article 56 of Regulation 2024/1689 on Artificial Intelligence (“AI Act”), the Code forms part of the regulation’s phased implementation and is intended to help GPAI model providers comply with their obligations, in particular those set out in […]